Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com
Patient has medical chart documentation of advanced (unresectable or metastatic) melanoma.
Patient initiated a first-line therapy for the treatment of advanced melanoma during the eligibility period (01 July 2016 to 01 July 2017; index event).
Patient did not receive systemic treatment for their advanced (unresectable or metastatic) melanoma prior to index event
Patient initiated first-line therapy at least six months before the date their chart abstraction initiated
You may not be if
Patient was enrolled in an investigational drug clinical trial or participating in medical research judged to directly affect how the patient was being monitored/treated while receiving first-line therapy
Patient had another active concurrent malignancy other than advanced melanoma, which required systemic treatment at the time of index event
Part or all of the patient's first-line treatment was received at a different site and the patient's medical chart pertaining to this care is not accessible
Patient medical chart is missing, empty, or not retrievable
Clareo Health | Study of First-line Treatment Patterns and Clinical Outcomes in Patients With Advanced Melanoma in the United Kingdom
